Business Description
Anhui Heryi Pharmaceutical Co Ltd
ISIN : CNE100005W81
Total Employee Number:
485Compare
Compare
Traded in other countries / regions
920478.China IPO Date
2023-02-23Description
Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.71 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 1.75 | |||||
Interest Coverage | 40.9 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 8.31 | |||||
Beneish M-Score | -3.3 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17.6 | |||||
3-Year EBITDA Growth Rate | -20.8 | |||||
3-Year EPS without NRI Growth Rate | -22.2 | |||||
3-Year Book Growth Rate | 5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 73.22 | |||||
9-Day RSI | 66.27 | |||||
14-Day RSI | 61.7 | |||||
3-1 Month Momentum % | 4.52 | |||||
6-1 Month Momentum % | -10.99 | |||||
12-1 Month Momentum % | -28.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.04 | |||||
Quick Ratio | 3.56 | |||||
Cash Ratio | 2.73 | |||||
Days Inventory | 201.84 | |||||
Days Sales Outstanding | 33.69 | |||||
Days Payable | 96.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.18 | |||||
Dividend Payout Ratio | 0.66 | |||||
Forward Dividend Yield % | 1.18 | |||||
5-Year Yield-on-Cost % | 1.29 | |||||
3-Year Average Share Buyback Ratio | -13.1 | |||||
Shareholder Yield % | -1.35 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.27 | |||||
Operating Margin % | 14.07 | |||||
Net Margin % | 13.47 | |||||
EBITDA Margin % | 14.06 | |||||
FCF Margin % | -35.77 | |||||
OCF Margin % | 24.05 | |||||
ROE % | 6.68 | |||||
ROA % | 5.56 | |||||
ROIC % | 8.02 | |||||
3-Year ROIIC % | -2.82 | |||||
ROC (Joel Greenblatt) % | 11.44 | |||||
ROCE % | 6.49 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 41.11 | |||||
PE Ratio without NRI | 41.11 | |||||
Shiller PE Ratio | 23.47 | |||||
PS Ratio | 5.65 | |||||
PB Ratio | 2.69 | |||||
Price-to-Tangible-Book | 2.87 | |||||
Price-to-Operating-Cash-Flow | 23.19 | |||||
EV-to-EBIT | 35.47 | |||||
EV-to-EBITDA | 35.47 | |||||
EV-to-Revenue | 4.99 | |||||
EV-to-FCF | -13.94 | |||||
Price-to-GF-Value | 1.21 | |||||
Price-to-Projected-FCF | 3.4 | |||||
Price-to-Graham-Number | 2.29 | |||||
| Price-to-Net-Current-Asset-Value | 7.65 | |||||
| Price-to-Net-Cash | 34.32 | |||||
Earnings Yield (Greenblatt) % | 2.82 | |||||
FCF Yield % | -6.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Heryi Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 253.51 | ||
| EPS (TTM) (Â¥) | 0.309 | ||
| Beta | 1.5099 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.59 | ||
| Volatility % | 24.21 | ||
| 14-Day RSI | 61.7 | ||
| 14-Day ATR (Â¥) | 1.111748 | ||
| 20-Day SMA (Â¥) | 10.9355 | ||
| 12-1 Month Momentum % | -28.15 | ||
| 52-Week Range (Â¥) | 7.83 - 19.114285 | ||
| Shares Outstanding (Mil) | 110.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Heryi Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Heryi Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.150000 Cash Dividend | 2026-05-20 | 11.19 (+3.98%) | ||
| 1.4:1 Stock Split | 2026-05-20 | 11.19 (+3.98%) | ||
| CNY 0.204079 Cash Dividend | 2025-05-29 | 14.80 (-3.33%) | ||
| 1.4:1 Stock Split | 2025-05-29 | 14.80 (-3.33%) |
Show
Entries
Anhui Heryi Pharmaceutical Co Ltd Frequently Asked Questions
What is Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478)'s stock price today?
The current price of BJSE:920478 is ¥12.70. The 52 week high of BJSE:920478 is ¥19.11 and 52 week low is ¥7.83.
When is next earnings date of Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478)?
The next earnings date of Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478) is .
Does Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478) is 1.18% (As of Today), Highest Dividend Payout Ratio of Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478) was 0.66. The lowest was 0.45. And the median was 0.46. The  Forward Dividend Yield % of Anhui Heryi Pharmaceutical Co Ltd(BJSE:920478) is 1.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Anhui Heryi Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers